Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Kedudukan dalam Saham #17486
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Harga Saham
$0.8034
Modal Pasaran
$236.69M
Perubahan (1 hari)
-8.69%
Perubahan (1 tahun)
-22.00%
Negara
US
Perdagangan Invivyd, Inc. (IVVD)

Kategori

Sejarah pecahan saham untuk Invivyd, Inc. (IVVD)
Saham Invivyd, Inc. (simbol: IVVD) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Sep 02, 2026.
Satu saham IVVD yang dibeli sebelum Sep 02, 2026 kini bersamaan dengan 0 saham IVVD.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH